AI-Integrated High-Throughput Screening Platform

inquiry

Creative Enzymes operates an automated screening infrastructure that combines intelligent variant prioritization with high-throughput experimental validation. The platform transforms massive variant pools into ranked candidate lists through AI-guided selection, automated assay execution, and quantitative activity analysis.

Challenges in Traditional Screening

Enzyme engineering generates more variants than laboratories can practically evaluate:

Massive Variant Numbers

Random mutagenesis, site-saturation libraries, and combinatorial designs routinely produce 10⁴–10⁶ variants. Exhaustive experimental evaluation is infeasible with standard laboratory infrastructure.

Low Efficiency

Beneficial variants represent a small fraction of most libraries. Screening effort is consumed evaluating neutral or deleterious mutants, with hit rates frequently below 1%.

Experimental Burden

Large-scale screening demands substantial reagent consumption, personnel time, and analytical capacity. Cost scales with library size, not with productive output.

Limited Throughput

Manual screening methods cannot match the generation rate of modern library construction techniques. Bottlenecks shift from design to validation, stalling project progress.

These challenges demand screening infrastructure that prioritizes intelligently, operates automatically, and scales to match library diversity.

AI-Assisted Screening Platform

Intelligent Candidate Prioritization

Machine learning models rank variants by predicted activity, stability, and expression before experimental testing. Screening concentrates on pre-qualified candidates with substantially higher expected hit rates than random subsets.

Automated Screening Support

Robotic liquid handling, plate preparation, and assay execution operate with minimal manual intervention. Scheduling algorithms optimize equipment utilization and result turnaround.

Activity Profiling

Spectrophotometric, fluorometric, and chromatographic assays measure kinetic parameters, substrate scope, and stereoselectivity across diverse reaction chemistries. Assay miniaturization enables thousands of measurements per campaign.

Variant Ranking

Multi-parameter scoring integrates activity, stability, and expression data into unified candidate rankings. Pareto-optimal variants balancing competing properties are identified for downstream validation.

Stability Screening

Thermal shift analysis, residual activity after stress exposure, and aggregation kinetics characterize operational robustness under process-relevant conditions.

Functional Prediction

Sequence and structure-based models predict functional outcomes for variants not screened experimentally, extrapolating from measured data to expand the effective coverage of each campaign.

Screening Workflow

1. Variant Library: Input variants from random mutagenesis, site-saturation, recombination, or computational design. Library sizes from hundreds to millions are accommodated.

2. AI-Based Ranking: Each variant is scored by activity, stability, and expression predictors. Composite rankings organize variants into screening tiers based on predicted performance and confidence.

3. Focused Screening: Top-tier variants are subjected to high-throughput experimental assays. Screening depth is calibrated to predicted hit density, avoiding wasted effort on low-probability candidates.

4. Activity Analysis: Assay results are analyzed for kinetic parameters, substrate preferences, and stereochemical outcomes. Variants are benchmarked against parent enzyme and positive controls.

5. Candidate Selection: Top-performing variants are selected for secondary validation and scale-up. Selection criteria balance primary activity with stability, expressibility, and predicted manufacturability.

Supported Screening Types

Activity Screening

Kinetic characterization of turnover rate, substrate affinity, and catalytic efficiency under standardized assay conditions.

Substrate Profiling

Evaluation of substrate scope, specificity, and selectivity across compound libraries or natural metabolite panels.

Stability Screening

Thermal tolerance, pH resilience, organic solvent resistance, and long-term operational half-life under stress conditions.

Expression Screening

Total yield, soluble fraction, monomeric purity, and secretion efficiency in standard production hosts.

Applications

Directed Evolution

Iterative screening of focused libraries with feedback into subsequent design cycles.

Enzyme Optimization

Multi-property screening of rationally designed variants for activity, stability, and expression improvement.

Biocatalyst Development

Process-condition screening to identify enzymes compatible with manufacturing requirements.

Case Study

High-Throughput Enzyme Engineering for Sustainable Biocatalysis

High-Throughput Enzyme Engineering for Sustainable Biocatalysis Figure 1. High-throughput technologies for selecting superior biocatalysts. (Bozkurt et al., 2026)

This review examines emerging strategies for discovering, engineering, and optimizing enzymes for industrial biocatalysis and sustainable chemical production. It highlights the integration of enzyme engineering, computational design, automated DNA assembly, and high-throughput screening to develop biocatalysts with improved performance. Advances in library construction technologies, including microfluidics, liquid handling systems, Gibson Assembly, and Golden Gate Assembly, have streamlined the generation of enzyme variants and reduced experimental workload. The review also discusses methods for identifying and characterizing promising biocatalysts for natural product synthesis and other applications. Together, these innovations accelerate enzyme development and support the transition toward a more efficient and environmentally sustainable bioeconomy.

Related High-Throughput Screening Services

Creative Enzymes offers high-throughput enzyme screening, activity profiling, substrate specificity analysis, stability screening, and automated biochemical characterization services to support AI-assisted candidate prioritization workflows.

FAQs

Q: What throughput does the platform support?

A: Thousands of variants per week for standard assays; tens of thousands for miniaturized primary screens. Throughput scales with assay complexity and characterization depth.
Q: How does AI prioritization improve hit rates?

A: Pre-screening by predicted activity and stability concentrates experimental effort on variants with higher probability of improvement. Hit rates typically increase 5–10× compared to random screening of equivalent library size.
Q: Can you screen for multiple properties simultaneously?

A: Yes. Primary screens measure activity; secondary screens characterize stability, expression, and substrate scope. Multi-parameter ranking identifies variants with balanced property profiles.
Q: What assay formats are available?

A: Spectrophotometric, fluorometric, HPLC, and mass spectrometry-based assays. Custom assay development is supported for novel reaction chemistries.
Q: How quickly can screening campaigns be initiated?

A: Standard assays require 1–2 weeks for protocol adaptation and validation. Custom assays require 3–4 weeks for development and calibration.
Q: Can screening integrate with your design services?

A: Yes. Libraries designed through AI-Guided Mutant Library Design are formatted for direct input into screening prioritization. Results feed back into design models for iterative improvement.

First Name:

Last Name:

Email *

Phone Number:

Company/Institution:

Country or Region:

Quantity:

Services & Products of Interested *

Project Description:

For research and industrial use only. Not intended for personal medicinal use. Certain food-grade products are suitable for formulation development in food and related applications.

Services

Online Inquiry